X-ZELL is an award-winning medical technology company specializing in the detection and digitization of atypical cells from body liquids such as blood and pleural fluid. Atypical cells are the universal language of cancer diagnostics and commonly found in tissue or fluid samples that were surgically collected from the suspected site. By enabling cytology to detect atypical cells in non-invasive sample material and process them digitally at a new level of detail, we make highly accurate, non-invasive cancer diagnostics accessible at scale.